Item 2.02 Results of Operations and Financial Condition.

On November 5, 2020, MyoKardia, Inc. announced its financial results for the third quarter ended September 30, 2020. The full text of the press release issued in connection with the announcement is furnished as Exhibit 99.1 to this Current Report on Form 8-K.

The information in Item 2.02 of this Form 8-K (including Exhibit 99.1) shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference under the Securities Act of 1933, as amended, except as expressly set forth by specific reference in such a filing.

Item 9.01 Financial Statements and Exhibits.



(d) Exhibits.



Exhibit No.                                 Description

99.1            Press Release issued by MyoKardia, Inc. on November 5, 2020, furnished
              herewith
104           Cover Page Interactive Data File (embedded within the Inline XBRL
              document).









--------------------------------------------------------------------------------

© Edgar Online, source Glimpses